REGENXBIO Completes Enrollment in Pivotal Duchenne...
Category : Clinical Trial Update 1 November 2025REGENXBIO Inc. has reached two major milestones in its Duchenne muscular dystrophy (DMD) program &md...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Shanghai Zhimeng Begins Phase 2/3 Trial of Novel P...
Category : Clinical Trial Update 1 November 2025Shanghai Zhimeng Biopharma Inc. has officially launched the Phase 2/3 clinical trial of its new-gene...
Vesper Bio Reports Promising Phase Ib/IIa Results...
Category : Clinical Trial Update 1 November 2025Vesper Bio ApS, a clinical-stage biotech focused on neurodegenerative and neuropsychiatric diseases,...
Aldeyra Therapeutics Reports Positive Liver Functi...
Category : Clinical Trial Update 31 October 2025Aldeyra Therapeutics Inc., a biotechnology company focused on developing therapies for immune-mediat...
ChemDiv Extends CMC Collaboration for Ratutrelvir,...
Category : Licensing/Collaboration Deal 31 October 2025ChemDiv Inc., a global provider of integrated drug discovery solutions, announced the extension of i...
Latest Newsletter Post
-
Vesper Bio Reports Promising Phase..
1 November 2025
-
Shanghai Zhimeng Begins Phase 2/3 T..
1 November 2025
-
REGENXBIO Completes Enrollment in P..
1 November 2025
-
Alys Pharmaceuticals Doses First Su..
31 October 2025
-
ChemDiv Extends CMC Collaboration f..
31 October 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com